3-Pyridylacetic acid-d₄ hydrochloride

Cat. No.: HY-W004515S: FAQs
Data Sheet Handling Instructions

Molarity Calculator

3-Pyridylacetic acid-d₄ (hydrochloride) is the deuterium labeled 3-Pyridylacetic acid hydrochloride[1]. 3-Pyridineacetic acid hydrochloride is a higher homologue of nicotinic acid, a breakdown product of nicotine (and other tobacco alkaloids)[2][3].

For research use only. We do not sell to patients.

3-Pyridylacetic acid-d<sub>4</sub> hydrochloride Chemical Structure

3-Pyridylacetic acid-d₄ hydrochloride Chemical Structure

CAS No. : 1219802-37-5

Size		Stock
1 mg		Get quote	Estimated Time of Arrival: December 31

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Other Forms of 3-Pyridylacetic acid-d₄ hydrochloride:

3-Pyridylacetic acid hydrochloride Get quote

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description	3-Pyridylacetic acid-d₄ (hydrochloride) is the deuterium labeled 3-Pyridylacetic acid hydrochloride[1]. 3-Pyridineacetic acid hydrochloride is a higher homologue of nicotinic acid, a breakdown product of nicotine (and other tobacco alkaloids)[2][3].
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. 3-Pyridylacetic acid-d₄ hydrochloride Related Antibodies
Molecular Weight	177.62
Formula	C₇H₄D₄ClNO₂
CAS No.	1219802-37-5
Unlabeled CAS	6419-36-9
SMILES	[2H]OC(C([2H])([2H])C1=CN=CC=C1)=O.Cl[2H]
Shipping	Room temperature in continental US; may vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation	Data Sheet (270 KB) Handling Instructions (2659 KB)
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief] [2]. GINOULHIAC E, et al. 3-Pyridineacetic acid and nicotinic acid: blood levels, urinary elimination and excretion of nicotinic acid derivatives in man. Nature. 1962 Mar 10;193:948-9. [Content Brief] [3]. Zwickenpflug W, et al. Metabolism of myosmine in Wistar rats. Drug Metab Dispos. 2005 Nov33(11):1648-56. [Content Brief]